Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock enjoyed a major increase of 42.9% on 11/8/24. The shares closed at $22.07. Moreover, trading volume in this advance was exceptionally high at 765% of normal. The stock has risen 61.9% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
RIGL is expected to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment